Insider Selling: Roka Bioscience, Inc. (ROKA) Major Shareholder Sells $125,048.98 in Stock
Roka Bioscience, Inc. (NASDAQ:ROKA) major shareholder Orbimed Advisors Llc sold 127,601 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The stock was sold at an average price of $0.98, for a total transaction of $125,048.98. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Orbimed Advisors Llc also recently made the following trade(s):
- On Wednesday, August 23rd, Orbimed Advisors Llc sold 1,100 shares of Roka Bioscience stock. The stock was sold at an average price of $1.50, for a total transaction of $1,650.00.
- On Thursday, August 24th, Orbimed Advisors Llc sold 14,300 shares of Roka Bioscience stock. The stock was sold at an average price of $1.50, for a total transaction of $21,450.00.
- On Tuesday, August 22nd, Orbimed Advisors Llc sold 75,276 shares of Roka Bioscience stock. The stock was sold at an average price of $1.52, for a total transaction of $114,419.52.
Roka Bioscience, Inc. (NASDAQ:ROKA) opened at 0.73 on Friday. The company’s market capitalization is $3.66 million. Roka Bioscience, Inc. has a 52 week low of $0.69 and a 52 week high of $9.30. The stock’s 50 day moving average is $1.62 and its 200 day moving average is $2.79.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/insider-selling-roka-bioscience-inc-roka-major-shareholder-sells-125048-98-in-stock/1600527.html.
A hedge fund recently bought a new stake in Roka Bioscience stock. AWM Investment Company Inc. acquired a new stake in shares of Roka Bioscience, Inc. (NASDAQ:ROKA) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 132,297 shares of the medical research company’s stock, valued at approximately $352,000. AWM Investment Company Inc. owned approximately 2.64% of Roka Bioscience as of its most recent SEC filing. Institutional investors and hedge funds own 66.51% of the company’s stock.
About Roka Bioscience
Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.
Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.